Proteostasis Therapeutics Inc. Stock News

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$1.08

+0 (+0%)

At Close: Aug 17, 2022

Noor Muqaddam: The high society beheading that stunned a nation

12:21am, Friday, 25'th Feb 2022 Kwhen Finance

Solve Industrial Motion Group Acquires Bearings Limited and Tritan Brand

01:00pm, Thursday, 16'th Dec 2021 Kwhen Finance

Yumanity Therapeutics Sees Lead Candidate Interim Data From Early-Stage Parkinson's Study By Mid-2021

12:02pm, Wednesday, 10'th Feb 2021

Yumanity Therapeutics Inc (NASDAQ: YMTX) reported results from the Phase 1 single ascending dose study in 40-healthy volunteers, evaluating its lead candidate, YTX-7739, an SCD inhibitor, for the t

Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio

10:47am, Tuesday, 22'nd Dec 2020

BOSTON, Dec. 22, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. ("Proteostasis") (Nasdaq: PTI) announced today that, based on the final vote count certified by the inspector of elections at its

Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results

04:15pm, Monday, 16'th Nov 2020

BOSTON, Nov. 16, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company, today announced financial results for the third quarter ended September

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In